The Paradigm Shift from Traditional Scientific Platforms to Integrated Communications Plans
In the rapidly evolving biopharma landscape, the approach to scientific communications is undergoing a significant transformation. The shift from traditional scientific platforms to integrated communications plans (ICPs) is becoming increasingly crucial for ensuring cohesive and impactful messaging. This article delves into the components, implementation, and benefits of an ICP tailored for the biopharma industry, addressing the challenges of fragmented messaging and the need for a unified communication strategy...
Read MoreTop Stories
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
It’s Never Too Soon: How and When to
Engagement with Medical Affairs is critical at every...
Celebrating Health Literacy Month 2024:
October is Health Literacy Month, a reminder of the...
Filter
New Open Data Sharing Policies: WHO and NIH Take Big Steps to Improve Public Health
Making research and data reproducible is vital to improving public health and reinstating trust in...
Which Regulatory Requirements Are Applicable to “Legacy” Devices?
Understanding the requirements for your medical device is vital in today’s market. But are these...
Effectiveness of Artificial Intelligence-Powered Translation Tools in Developing Medical Publications: An Assessment of Japanese-to-English Translation
Artificial intelligence (AI)–powered translation tools are gaining attention and acceptance to increase efficiency in medical...
Avoid the Pitfall of Image Manipulation
8 major publishers unite to solve the image manipulation problem in research publications. Here's a...
MedTech Summit 2021: Understanding Post Market Clinical Follow Up (PCMF)
An ideal PMCF plan, with reference to MDCG 2020-7, presents the general and specific methods...
Bringing New Devices to Market under the EU MDR
With the MDR coming into effect, the manufacturers should plan and construct their strategy to...